Renal Calculi Clinical Trial
Official title:
Super-Mini Percutaneous Nephrolithotomy (SMP) Versus Retrograde Intrarenal Surgery (RIRS) for Symptomatic Lower Pole Renal Calculi of 10-20 mm Size: a Randomized Controlled Trial (IAU-01)
Shock wave lithotripsy (SWL) is recommended for kidney stones < 20 mm. However, the stone
clearance of lower pole calculi after SWL is limited, thus leading to an extended indication
for mini-percutaneous nephrolithotripsy (PCNL) even for stones between 10 and 20 mm in many
centers. This trend is further promoted by introduction of super-mini PCNL (SMP), which is
postulated to be less invasive compared to mini-PCNL due to the miniaturized instruments.
However, this issue remains controversial.
On the other hand, improvements in endoscopy technology have made retrograde stone removal
more attractive. This has led to an increasing use of RIRS as a primary treatment although it
is recommended only as 2nd-line option by current guidelines. However, the treatment of
symptomatic lower pole calculi is a challenge for RIRS because of lower clearance rates.
The purpose of this study is to evaluate the efficacy and safety of SMP and RIRS for the
treatment for symptomatic lower pole calculi renal calculi measuring 10-20 mm.
To evaluate the efficacy and safety of SMP and RIRS for the treatment for symptomatic lower
pole calculi renal calculi measuring 10-20 mm.Investigators will do a multi-centers
international randomized controlled trial(RCT),and investigators plan to perform this study
in 10 hospitals,which are the First Affiliated Hospital of Guangzhou Medical University of
China, Department of Urology, Renmin Hospital, Wuhan University of China, Shenzhen People's
Hospital of China, The Second Affiliated Hospital of Zhengzhou University of China, The
Second Affiliated Hospital of Harbin Medical University of China, Zhujiang Hospital of
Southern Medical University of China, Jiangsu Province hospital, The First Affiliated
Hospital With Nanjing Medical University of China, Zhejiang provincial people's hospital of
china, Dr. Lutfi Kirdar Training and Research Hospital of Turkey and Global Rainbow
Healthcare of India respectively.
Investigators plan to beginning their study at August in 2015 and end at July in 2017.One
hundred and sixty patients with symptomatic lower pole calculi renal calculi measuring 10-20
mm will be enrolled in this study. By simple random sampling technique, patients will be
assigned to two 80-patient groups.All the patients will be diagnosed definitely before
operations with non-contrast CT.Patients with positive preoperative urine culture should be
treated with suitable antibiotics based on the culture sensitivity result for at least 72h
before SMP/RIRS. Patients who have negative urine culture should receive a single dose of
broad spectrum antibiotic prophylaxis just prior to the procedure.
Surgical technique
SMP
All the biochemistry tests and preoperative preparations are referenced to the mini-PCNL.
Under general anesthesia a 6 French(Fr).Open end ureteral catheter is first inserted in to
the relevant ureter. Patient is then turned into prone position and the desired calyx is
punctured under fluoroscopic or sonographic guidance. Nephrostomy tract dilation is carried
out using fascial dilators up to 12-14 Fr. as indicated. Corresponding size of
suction-evacuation sheath was placed. The sheath is connected to the specimen collection
bottle and the bottle then onto the aspirator. A rubber cap with a center aperture was placed
at the proximal end of the sheath. The negative pressure aspirator was adjusted to a setting
of 150-200 mm Hg. The miniature endoscope is inserted into the sheath through the cap. Stone
is visualized and lithotripsy is performed using either Holmium-yttrium aluminum garnet(YAG)
laser or pneumatic lithotripsy. At the end of procedure fluoroscopic images are obtained to
assess stone clearance status. Double J ureteral stent is placed only in the presence of
ureteral inflammatory polyp; evidence of ureteropelvic obstruction; presence of significant
pyelocalyceal blood clots following lithotripsy; significant residual stones. Indications for
nephrostomy tube placement included: significant residual stone fragments which would require
a second look procedure; significant pyelocalyceal blood clots or bleeding after lithotripsy
(because the nephrostomy tube could tamponade the access tract and drain the urine and
clots).
RIRS
The patient is placed in the lithotomy position, Cystoscopy and retrograde pyelogram were
preformed, and a 0.035'' flexible tip guidewire is placed into the renal pelvis. A 12 Fr/ 14
Fr ureteral access sheath (UAS) is advanced into the proximal ureter over the guidewire, and
a P5 or P6 Olympus flexible ureteroscope is passed through the UAS. The stones are fragmented
using a 200um holmium laser fibre at a 8-25 weeks energy setting. Some fragments are removed
using a stone basket for stone analysis, and the remaining stone fragments smaller than 2 mm
were left for spontaneous passage. A 5 Fr or 6Fr pigtail stent is placed at the conclusion of
the procedure. Double J stents were removed post-operative 2 weeks.
Data collection
Data for the 2 groups-demographic characteristics,hemoglobin(HB) decrease, postoperative
pain, duration of postoperative, hospital stay, complications (modified Clavien system),
stone clearance (SFR after day 1 and final SFR) and the need for auxiliary treatment are
compared.
Mean study endpoint: The primary endpoint was the SFR at 3-months after surgery.
Secondary endpoint: Complications, duration of postoperative and hospital stay. re-SMP,
ureteroscopy and SWL are considered as auxiliary treatments. Demographic characteristics
include age, sex, BMI, stone size and location, etc…
The stone size is defined as the maximum diameter as determined by CT scans.
Degree of hydronephrosis are assigned as follow: none (no calyx or pelvic dilation), mild
(pelvic dilatation alone), moderate (mild calyx dilation), or severe (severe calyx dilation
or calyx dilation accompanied by renal parenchyma atrophy).
Definition of operation time:
For SMP: recorded from the time of the first percutaneous renal puncture to the completion of
the stone removal.
For RIRS: recorded from insertion of an endoscope into the urethra to the completion of stent
placement.
Hospital stay are rounded to the nearest whole day and calculated from the day of surgery to
the day of discharge.
Postoperative pain (visual analogue scale(VAS), use of analgesics) and Postoperative comfort
scores (Bruggrmann comfort scale,BCS) will be recorded.
The rate of hemoglobin decrease is assessed by comparing the preoperative Hb level with
24-hour postoperative Hb level.
SFR is assessed by KUB and ultrasound at 1-day after operation.
Non-contrast CT is obtained for all patients at 3 month after the operation to evaluate the
final SFR, allowing time for the spontaneous passage of stone fragments.
Stone-free status are defined as either the absence of any residual stone fragments or the
presence of clinically insignificant residual stone fragments in the kidney which were
defined as ≦ 3mm, asymptomatic, non-obstructive and non-infectious stone particles.
If the procedure is considered as successful, the pigtail stent is removed as outpatient
after 2 weeks. Follow-up including non-contrast CT will be generally scheduled in 3 month.
Bleeding severity is judged by the treating physician, and transfusions are administered
according to local practice guideline.
Complications of all patients are recorded according to modified Clavien classification
system.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01450566 -
Intraureteral Lidocaine for Post-Ureteroscopy Pain
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Not yet recruiting |
NCT01008267 -
Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia.
|
N/A | |
Completed |
NCT00250406 -
Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation
|
Phase 2 | |
Recruiting |
NCT00169806 -
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
|
N/A | |
Not yet recruiting |
NCT02734914 -
Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure
|
N/A | |
Completed |
NCT00169741 -
Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC
|
N/A | |
Completed |
NCT05972408 -
Evaluation of Prevalence, Molecular and Genetic Backgrounds of Calcium-Based Stones Among Patients With Renal Calcular Disease in Mansoura Urology and Nephrology Center
|
||
Enrolling by invitation |
NCT02408211 -
Preoperative Antibiotic PNL Study
|
Phase 4 | |
Completed |
NCT01437904 -
A Pilot Study Assessing The Feasibility Of Outpatient Tubeless Percutaneous Nephrolithotomy (PCNL)
|
N/A | |
Completed |
NCT00857090 -
Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones
|
Phase 1/Phase 2 | |
Recruiting |
NCT05240170 -
RIRS for Treatment of Stones in Congenital Anomalous Kidneys
|
N/A | |
Completed |
NCT03112499 -
The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injury
|
N/A | |
Recruiting |
NCT03206515 -
The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones
|
N/A | |
Completed |
NCT03344107 -
Stent-related Symptoms Comparison: Polaris Loop vs Vortek Double-J Stents
|
N/A | |
Recruiting |
NCT05077007 -
Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers
|
N/A | |
Completed |
NCT03614247 -
Cost-Effectiveness of Different Treatment Options for Lower Calyceal Stones
|
N/A | |
Recruiting |
NCT05739812 -
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
|
N/A | |
Recruiting |
NCT05869890 -
Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi
|
N/A | |
Completed |
NCT00893282 -
Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy
|
N/A |